Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Related Posts
Stocks Are in a Bull Market. What Does That Mean?
The S&P 500 index closed at a record on Friday, crossing above its old high-water mark, set in early 2022. The gains show that investors […]
What Can the Department of Government Efficiency Do?
President-elect Trump has indicated the entity will operate outside the government, a position that comes with legal limits.
The Allure (and Complications) of “Golden Shares”
The White House would like some control of U.S. Steel if it approves its sale to Nippon Steel. Such deals could alter foreign investment in […]